Filing Details

Accession Number:
0001179110-16-022552
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-01 17:08:06
Reporting Period:
2016-03-31
Filing Date:
2016-04-01
Accepted Time:
2016-04-01 17:08:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
815094 Abiomed Inc ABMD Surgical & Medical Instruments & Apparatus (3841) 042743260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1200493 E Dorothy Puhy C/O Abiomed, Inc.
22 Cherry Hill Drive
Danvers MA 01923
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Disposition 2016-03-31 4,398 $95.01 47,792 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2016-04-01 5,602 $95.02 42,190 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock option (right to buy) $12.69 2008-08-13 2017-08-08 0 8,000 Direct
Common Stock Stock Option (right to buy) $18.63 2009-08-12 2018-08-13 0 13,500 Direct
Common Stock Stock Option (right to buy) $7.67 2010-08-11 2019-08-12 0 13,500 Direct
Common Stock Stock Option (right to buy) $9.99 2011-08-10 2020-08-11 0 13,500 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2017-08-08 0 8,000 Direct
2018-08-13 0 13,500 Direct
2019-08-12 0 13,500 Direct
2020-08-11 0 13,500 Direct
Footnotes
  1. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
  2. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
  3. This option becomes exerciseable in full on the date set forth in Table II, Column 6.
  4. Sale of common stock pursuant to reporting owner's 10b5-1 plan.
  5. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $95.0000 and $95.0900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  6. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $95.0000 and $95.0500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.